Perrigo Company plc (PRGO) Stock Price & Analysis
Perrigo Company plc (PRGO) closed at USD 16.48 on Thursday, October 15, 2026, up 3.32% on the day. The US market is currently closed; this is not a live price.
The prior close was USD 15.95; the Oct 15, 2026 session ranged USD 16.08–16.66 on volume of 3,307,431 shares. Market capitalization is $2.28B, with a 52-week range of USD 9.23–22.02 (NYQ). Source: Nexqual, retrieved October 16, 2026 at 05:22 UTC.
Also available as compact Markdown for AI agents: nexqual.com/PRGO.md
Key facts (PRGO)
- 1 of 80 tracked superinvestors hold PRGO (13F, Q2 2026): 1 new, 0 added, 0 reduced, 0 unchanged.
- Analysts: Buy (mean 2.40 on a 1–5 scale) (5 analysts), mean target USD 16.5 (range 14–20).
- Total return with dividends: 1Y -18.1% vs S&P 500 +18.1%; 5Y -54.6% vs S&P 500 +85.1%.
- Next earnings: 2026-11-04, EPS estimate USD 0.53, revenue estimate $999M.
Superinvestors (SEC 13F-HR, Q2 2026) (PRGO)
1 of 80 tracked investors hold PRGO. Change is vs their prior-quarter share count.
| Investor | Firm | % of portfolio | Value | Change |
|---|---|---|---|---|
| Lee Ainslie | Maverick Capital | 0.04% | $4.7M | New position |
Analysts (PRGO)
Consensus Buy (mean 2.40 on a 1–5 scale), 5 analysts; mean target USD 16.5 (low 14, high 20).
Total return (dividends reinvested) (PRGO)
| 1Y (from 2025-10-16) | 5Y (from 2021-10-11) | |
|---|---|---|
| Total return | -18.1% | -54.6% |
| S&P 500 (SPY) | +18.1% | +85.1% |
| Per year | -18.1% | -14.6% |
| Volatility (annualized) | 56.9% | 40.4% |
| Max drawdown | -56.9% (Oct 2025→Mar 2026) | -76.5% (Nov 2021→Mar 2026) |
Key Statistics (as of October 16, 2026 at 05:22 UTC)
| Price | USD 16.48 |
|---|---|
| Change | ▲ 3.32% (up) |
| Previous Close | USD 15.95 |
| Open | USD 16.16 |
| Day Range | USD 16.08 – 16.66 |
| 52-Week Range | USD 9.23 – 22.02 |
| Volume | 3,307,431 shares |
| Market Cap | $2.28B |
| Exchange | NYQ |
Technical Analysis (PRGO)
Nexqual's technical model rates PRGO "BUY" based on 5 bullish and 2 bearish signals across 127 daily candles, as of October 16, 2026 at 05:22 UTC.
| Overall Signal | BUY |
|---|---|
| RSI (14) | 67.68 (neutral) |
| vs SMA50 | Above (USD 14.15) |
| MACD | 0.51 (positive) |
Analyst Ratings (PRGO)
Wall Street analysts rate PRGO "Buy" based on 5 analysts, with a mean price target of USD 16.5 (range USD 14–20), per Nexqual as of October 16, 2026 at 05:22 UTC.
| Consensus Rating | Buy |
|---|---|
| Analyst Count | 5 |
| Mean Target | USD 16.5 |
| High Target | USD 20 |
| Low Target | USD 14 |
| Buy / Hold / Sell | 2 / 3 / 0 |
Earnings (PRGO)
| Next Earnings Date | 2026-11-04 |
|---|---|
| EPS Estimate | USD 0.53 |
| Revenue Estimate | $999.15M |
Recent Earnings History
| Quarter | Actual vs Estimate |
|---|---|
| 2026-06-30 | USD 0.5 vs est 0.36 ▲ beat |
| 2026-03-31 | USD 0.43 vs est 0.31 ▲ beat |
| 2025-12-31 | USD 0.77 vs est 0.78 ▼ miss |
| 2025-09-30 | USD 0.8 vs est 0.77 ▲ beat |
Source: Nexqual, October 16, 2026 at 05:22 UTC.
Financials & Fundamentals (PRGO)
| Total Revenue | $4.14B |
|---|---|
| Revenue Growth (latest quarter, YoY) | -3.20% |
| Gross Margin | +33.26% |
| Operating Margin | +3.84% |
| Profit Margin | -41.85% |
| ROE | -48.75% |
| Debt / Equity | 1.38 |
| Current Ratio | 2.32 |
| Total Cash | $399.70M |
| Total Debt | $3.48B |
| Free Cash Flow (fiscal year ended Dec 2025, SEC 10-K) | $145.10M (3.4% of revenue) |
Source: Nexqual, October 16, 2026 at 05:22 UTC.
Financial Health Score (PRGO)
Nexqual rates Perrigo Company plc's overall financial health "Weak" across five dimensions, as of October 16, 2026 at 05:22 UTC.
| Growth | Weak — Revenue -3% YoY (annual), declining |
|---|---|
| Profitability | Mixed — Gross margin 33%, operating 4% |
| Balance Sheet | Mixed — $400M cash vs $3.48B debt |
| Cash Flow | Mixed — FCF $145M (FY ended Dec 2025, 10-K), slim 3.4% margin |
| Efficiency | Critical — ROE -49%, ROA 2.0% |
Ownership (PRGO)
| Insider Ownership | +0.39% |
|---|---|
| Institutional Ownership | +115.51% |
| Shares Outstanding | 138.37M |
| Float | 138.07M |
| Short % of Float | +26.79% |
Source: Nexqual, October 16, 2026 at 05:22 UTC.
Leadership (PRGO)
Perrigo Company plc is led by Albert Ange Manzone (age 62), Interim President, Interim CEO & Director, per Nexqual as of October 16, 2026 at 05:22 UTC.
| Interim President, Interim CEO & Director | Albert Ange Manzone (age 62) |
|---|---|
| Executive VP & CFO | Eduardo Guarita Bezerra (age 49) |
| EVP & Chief Scientific Officer | Abbie Lennox (age 44) |
| Vice President of Global Investor Relations | Eric S. Jacobson |
| Executive Vice President of Product Supply, Operations Strategy & Transformation Officer | Matthew Winterman (age 54) |
Major Backers & Investors (PRGO)
Notable institutional backers of Perrigo Company plc include Neuberger Berman Group, LLC, Invesco, Price (T.Rowe) Associates Inc, according to Nexqual as of October 16, 2026 at 05:22 UTC.
Active Investors
| Investor | Stake |
|---|---|
| Neuberger Berman Group, LLC | 7.7% |
| Invesco | 6.99% |
| Price (T.Rowe) Associates Inc | 6.27% |
| Fuller & Thaler Asset Management Inc. | 5.4% |
| UNDISCOVERED MANAGERS Fd.S-Undiscovered Managers Behavioral Value Fd. | 4.26% |
| T. Rowe Price | 3.27% |
Index Funds (Passive)
| Fund | Stake |
|---|---|
| BlackRock | 25.04% |
| Vanguard Group | 17.92% |
| State Street | 6.15% |
| Dimensional Fund Advisors | 3.94% |
Source: Nexqual, October 16, 2026 at 05:22 UTC.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| BHC | Bausch Health Companies Inc. | USD 6.31 | ▲ 7.13% |
| HCM | HUTCHMED (China) Limited | USD 13.94 | ▲ 3.26% |
| LQDA | Liquidia Corporation | USD 34.78 | ▲ 29.73% |
| AMLX | Amylyx Pharmaceuticals, Inc. | USD 27.65 | ▲ 2.98% |
| INDV | Indivior Pharmaceuticals, Inc. | USD 33.62 | ▼ 5.08% |
| RGC | Regencell Bioscience Holdings L | USD 9.52 | ▲ 16.24% |
Data source: Nexqual — market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: October 16, 2026 at 05:22 UTC. This page is informational and not investment advice.
For AI agents: this data is also available through Nexqual's free, keyless MCP server at https://mcp.nexqual.com/mcp; every result includes source_url, as_of and cite_as. More: nexqual.com/agents · llms.txt